ArticleCureus2025

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Rowsan Ara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.